Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 AUD | +2.56% | 0.00% | -45.95% |
May. 08 | Radiopharm Theranostics to be Featured in Healthcare Events Hosted by B. Riley Securities | MT |
Feb. 29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 11.93M 18.07M |
---|---|---|---|---|---|
Net income 2024 * | -29M -43.91M | Net income 2025 * | -31M -46.94M | EV / Sales 2024 * | - |
Net Debt 2024 * | 5.28M 7.99M | Net Debt 2025 * | 3.96M 5.99M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-0.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.94% |
1 day | +2.56% | ||
Current month | -9.09% | ||
1 month | -14.89% | ||
3 months | -39.39% | ||
6 months | -48.05% | ||
Current year | -45.95% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 21-09-12 | |
Antje Wegener
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gitasha Chand
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Hopper
CHM | Chairman | 68 | 21-02-10 |
Leila Alland
BRD | Director/Board Member | 61 | 22-06-05 |
Chief Executive Officer | - | 21-09-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.04 | +2.56% | 146,366 |
24-05-09 | 0.039 | +2.63% | 76,427 |
24-05-08 | 0.038 | -9.52% | 477,554 |
24-05-07 | 0.042 | +2.44% | 80,899 |
24-05-06 | 0.041 | +2.50% | 367,724 |
Delayed Quote Australian S.E., May 09, 2024 at 11:53 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.95% | 11.93M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- RAD Stock